FGFR1 tyrosine kinase domain duplication in infantile soft tissue spindle cell tumor

[1]  E. Mardis,et al.  EGFR internal tandem duplications in fusion‐negative congenital and neonatal spindle cell tumors , 2022, Genes, chromosomes & cancer.

[2]  A. Cherniack,et al.  Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer , 2022, JCO precision oncology.

[3]  Yuehua Wu,et al.  Tyrosine kinase‐altered spindle cell neoplasms with EGFR internal tandem duplications , 2022, Genes, chromosomes & cancer.

[4]  M. G. Koerkamp,et al.  Infantile fibrosarcoma with an EGFR kinase domain duplication: Underlining a close relationship with congenital mesoblastic nephroma and highlighting a similar morphological spectrum. , 2022, Annals of diagnostic pathology.

[5]  Y. Fujii,et al.  Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors , 2019, Journal of Neuro-Oncology.

[6]  Jessica L. Davis,et al.  TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  K. Perry,et al.  Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases , 2018, Modern Pathology.

[8]  A. Folpe,et al.  Fibrous hamartoma of infancy: a clinicopathologic study of 145 cases, including 2 with sarcomatous features , 2017, Modern Pathology.

[9]  Jason Y. Park,et al.  EGFR Exon 20 Insertion/Duplication Mutations Characterize Fibrous Hamartoma of Infancy , 2016, The American journal of surgical pathology.

[10]  David T. W. Jones,et al.  Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors , 2016, Oncotarget.

[11]  M. Stevens,et al.  Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience. , 2016, European journal of cancer.

[12]  F. Mertens,et al.  FN1–EGF gene fusions are recurrent in calcifying aponeurotic fibroma , 2016, The Journal of pathology.

[13]  Heather L. Mulder,et al.  Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas , 2013, Nature Genetics.

[14]  Ming-Chih Crouthamel,et al.  Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity , 2007, Molecular Cancer Therapeutics.

[15]  P. Allen,et al.  Juvenile aponeurotic fibroma , 1970, Cancer.

[16]  L. E. Keasbey.  Juvenile aponeurotic fibroma (calcifying fibroma). A distinctive tumor arising in the palms and soles of young children , 1953, Cancer.